TB vaccine development: monitoring international patent filings to anticipate access challenges2025-2026M72/AS01e, MTBVACMaps international patent filings for two late-stage TB vaccine candidates, MTBVAC and M72/AS01E, as well as the QS-21 adjuvant used in M72/AS01E
